Watch ARQT. Know when insiders buy.
One email the day a filing lands. Free.
ARQT
Arcutis Biotherapeutics, Inc.
31.87
−0.95 −2.89%
USD · Oct 21, 07:40 p.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
24
FLAG · insiders 25, shorts 22
Insiders, 90 days
−$1.6M
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4BP/E 151.8DIV YIELD —FCF YIELD 0.98%REV TTM $464M +76.1%NET INCOME $28.5MNET DEBT $74.8M52W 19.50 – 32.82SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose ARQT in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
BlackRock, Inc.14.1%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.